HLA class II association with autoimmune hepatitis in Latin America: A meta-analysis

Autoimmunity Reviews

Volumn 8, Issue 4, 2009, Pages 325-331

  Duarte Rey, Carolina ^a,b   Pardo, Aryce L ^c   Rodríguez Velosa, Yolima ^a,b   Mantilla, Ruben D ^b   Anaya, Juan Manuel ^a,d   Rojas Villarraga, Adriana ^a,b  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b Unidad de Reumatología   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Autoimmune diseases; Autoimmune hepatitis; HLA antigens; Latin America; Major histocompatibility complex; Meta analysis

Indexed keywords

AMINO ACID; HLA ANTIGEN CLASS 2; HLA DQ2 ANTIGEN; HLA DQ3 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR5 ANTIGEN; UNCLASSIFIED DRUG;

ALLELE; AUTOIMMUNE HEPATITIS; DEMOGRAPHY; DISEASE COURSE; DISEASE PREDISPOSITION; GENE FREQUENCY; GEOGRAPHIC DISTRIBUTION; HUMAN; PROGNOSIS; PROTEIN BINDING; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; SOUTH AND CENTRAL AMERICA; SYSTEMATIC REVIEW;

ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS, AUTOIMMUNE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; LATIN AMERICA; MALE; YOUNG ADULT;

EID: 60649105599     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.11.005     Document Type: Review

References (40)

1. Czaja A.J., and Freese D.K. Diagnosis and treatment of autoimmune hepatitis. Hepatology 36 (2002) 479-497
2. Czaja A.J. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol 6 (2008) 379-388
3. Czaja A.J., Strettell M.D., Thomson L.J., Santrach P.J., Moore S.B., Donaldson P.T., et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 25 (1997) 317-323
4. Strettell M.D., Donaldson P.T., Thomson L.J., Santrach P.J., Moore S.B., Czaja A.J., et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 112 (1997) 2028-2035
5. Shankarkumar U., Amarapurkar D.N., and Kankonkar S. Human leukocyte antigen allele associations in type-1 autoimmune hepatitis patients from western India. J Gastroenterol Hepatol 20 (2005) 193-197
6. Yoshizawa K., Ota M., Katsuyama Y., Ichijo T., Matsumoto A., Tanaka E., et al. Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis. J Hepatol 42 (2005) 578-584
7. Djilali-Saiah I., Fakhfakh A., Louafi H., Caillat-Zucman S., Debray D., and Alvarez F. HLA class II influences humoral immunity in patients with type 2 autoimmune hepatitis. J Hepatol 45 (2006) 844-850
8. Johnson P.J., and McFarlane I.G. Meeting Report: International Autoimmune Hepatitis Group. Hepatology 18 (1993) 998-1005
9. Alvarez E., Berg P.A., Bianchi E.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
10. Fainboim L., Marcos Y., Pando M., Capucchio M., Reyes G.B., Galoppo C., et al. Chronic active autoimmune hepatitis in children strong association with a particular HLA-DR6 (DRB1*1301) haplotype. Hum Immun 41 (1994) 146-150
11. Marsh S.G.E., Albert E.D., Bodmer W.F., Bontop R.E., Dupont B., Erlich H.A., et al. Nomenclature for factors of the HLA system. In: Hansen J.A. (Ed). Immunobiology of the human MHC: proceedings of the 13th International Histocompatibility Workshop and Conference vol. I (2002), IHWG Press, Seattle, WA
12. Teufel A., Worns M., Weinmann A., Centner C., Piendl A., Lohse A.W., et al. Allelic sequence variation in the HLA class II genes and proteins in patients. World J Gastroenterol 12 (2006) 5513-5516
13. Muratori P., Czaja A.J., Muratori L., Pappas G., Maccariello S., Cassani F., et al. Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol 11 (2005) 1862-1866
14. Al-Chalabi T., Boccato S., Portman B.C., McFarlane I.G., and Henegan M.A. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 45 (2006) 575-583
15. Miyake Y., Iwasaki Y., Takaki A., Kobashi H., Sacaguchi K., and Shiratori Y. Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Intern Med 46 (2007) 1945-1949
16. Rafeey M., Kianrad M., and Hasani A. Autoimmune hepatitis in Iranian children. Indian J Gastro 26 (2007) 11-13
17. Fan L.Y., Tu X.Q., Cheng Q.B., Zhu Y., Feltens R., Pfeiffer T., et al. Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J Gastroenterol 10 (2004) 3056-3059
18. Choudhuri G., Somani S.K., Baba C.S., and Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease. BMC Gastroenterol 5 (2005) 27. http://www.biomedcentral.com/1471-230X/5/27 [Available from URL: http://www.biomedcentral.com/1471-230X/5/27]
19. Bittencourt P.L., Goldberg A.C., Cançado E.L., Porta G., Carrilho F.J., Farias A.Q., et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol 94 (1999) 1906-1913
20. Pando M., Larriba J., Fernandez G.C., Fainboim H., Ciocca M., Ramonet M., et al. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 30 (1999) 1374-1380
21. Vazquez-Garcia M.N., Alaez C., Olivo A., Debaz H., Perez-Luque E., Burguete A., et al. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Hepatol 28 (1998) 985-990
22. Fortes M.P., Machado I.V., Gil G., Fernandez-Mestre M., Dagher L., Leo R.V., et al. Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela. Liver Int 27 (2007) 1409-1416
23. Arango Barrientos M., Diaz Coronado J.C., Ortega Castrillon J.C., Restrepo Zapata J.C., Correa Arango G., Restrepo Gutierrez J.C., et al. Manifestaciones clínicas y paraclínicas de la hepatitis autoinmune en 48 pacientes de la ciudad de Medellín, 1980-2004. IATREIA 18 (2005) 160-166
24. Londoño M.C., Gonzalez L.A., Cavarriaga J.C., Munera V., Ramos F., Suarez L.D., et al. Aplicación del modelo diagnóstico del grupo internacional para la hepatitis autoinmune (GIHA) en una población de pacientes de Medellín, Colombia. Rev Col Gastroenterol 1 (2003) 16-19
25. Czaja A.J., and Donalson P.T. Gender effects and synergisms with histocompatibility leukocyte antigens in Type 1 autoimmune hepatitis. Am J Gastroenterol 97 (2002) 2051-2057
26. Seo S., Toutounjian R., Conrad A., Blatt L., and Tong M.J. Favorable outcomes of autoimmune hepatitis in a community clinic setting. J Gastroenterol Hepatol (2008). http://dx.doi.org/10.1111/j.1440-1746.2008.05365.x [Available from URL: http://dx.doi.org/10.1111/j.1440-1746.2008.05365.x]
27. Goldberg A.C., Bittencourt P.L., Mougin B., Cançado E.L., Porta G., Carrilho F.J., et al. Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus. Hum Immun 62 (2001) 165-169
28. Czaja A.J., Souto E.C., Bittencourt P.L., Cançado E.L., Porta G., Goldberg A.C., et al. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the Unites States. J Hepatol 37 (2002) 302-308
29. Doherty D.G., Donaldson P.T., Underhill J.A., Farrant J.M., Duthie A., Mieli-Vergani G., et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 19 (1994) 609-615
30. Jones E.Y., Fugger L., Stromnger J.L., and Siebold C. MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 6 (2006) 271-282
31. Fu X.T., Bono C.P., Woulfe S.L., Swearingen C., Summers N.L., Sinigaglia F., et al. Functional roles of DR(α,β1*0401) residues in t cell recognition. J Exp Med 181 (1995) 915-926
32. Castaño-Rodriguez N., Diaz-Gallo L.M., Pineda-Tamayo R., Rojas-Villarraga A., and Anaya J.M. Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. Autoimmun Rev 7 (2008) 322-330
33. Czaja A.J., Carpenter H.A., and Moore S.B. Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North America outside DR3 and DR4. Liver Int 26 (2006) 552-558
34. Radstake T.R., Barrera P., Albers M.J., Swinkels H.L., van de Putte L.B., and van Riel P.L. Genetic anticipation in rheumatoid arthritis in Europe. J Rheumatol 28 (2001) 962-967
35. Czaja A.J., and Carpenter H.A. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology 43 (2006) 532-538
36. Anaya J.M., Corena R., Castiblanco J., Rojas-Villarraga A., and Shoenfeld Y. The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity. Expert Rev Clin Immunol 3 (2007) 623-635
37. Lim Y.S., Oh H.B., Choi S.E., Kwon O.J., Heo Y.S., Lee H.C., and Suh D.J. Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule. J Hepatol 48 (2008) 133-139
38. Anaya J.M., Gómez L., and Castiblanco J. Is there a common genetic basis for autoimmune diseases?. Clin Dev Immunol 13 (2006) 185-195
39. Delgado-Vega A.M., and Anaya J.M. Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis. Autoimmun Rev 6 (2007) 402-408
40. Gorodezky C., Alaez C., Murguía A., Rodríguez A., Balladares S., Vazquez M., et al. HLA and autoimmune diseases: type 1 diabetes (T1D) as an example. Autoimmun Rev 5 (2006) 187-194